Company attributes
Industry
Location
Email Address
Phone Number
Founded Date
2014
Total Funding Amount (USD)
30,000
Latest Funding Type
Other attributes
Company Operating Status
Active
Gentec is a therapeutics company that is engaged in genetic edition using CRISPR-Cas9 technology. Gentec has managed to create the first private laboratory build a genetic edition using CRISPR-Cas9 technology in Mexico.
Genetic diseases are conditions or disorders where an individual's DNA plays a key role in the development of the disease. With the advanced technology of Gentec, identifying these disorders and increasing the knowledge of these diseases with the aim of improving health is achievable.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
